These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31358309)

  • 1. [Rituximab use in mucous membrane pemphigoid].
    Bertrand AS; Dereure O; Girard C; Bessis D; Guillot B
    Ann Dermatol Venereol; 2019 Oct; 146(10):659-661. PubMed ID: 31358309
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
    Flores-Climente V; Rozas-Muñoz E; Martínez-Grau A; Aucouturier F; Luna S; Baselga E
    Pediatr Dermatol; 2019 Nov; 36(6):984-985. PubMed ID: 31448438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.
    Witte M; Zillikens D; Shimanovich I
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427
    [No Abstract]   [Full Text] [Related]  

  • 4. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.
    Huff SB; Vasu S; Kaffenberger BH
    Int J Dermatol; 2019 Feb; 58(2):240-241. PubMed ID: 29707776
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab for patients with refractory mucous membrane pemphigoid.
    Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
    Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
    Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
    Front Immunol; 2018; 9():248. PubMed ID: 29520266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
    Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
    Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
    Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
    Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
    Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid.
    Shifera AS; Hong GH; Khan IR; Okeagu C; Thorne JE
    Am J Ophthalmol; 2021 Mar; 223():21-27. PubMed ID: 32976845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
    Taverna JA; Lerner A; Bhawan J; Demierre MF
    J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab preserves vision in ocular mucous membrane pemphigoid.
    Rübsam A; Stefaniak R; Worm M; Pleyer U
    Expert Opin Biol Ther; 2015 Jul; 15(7):927-33. PubMed ID: 25966960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid.
    Haefliger S; Horn MP; Suter VG; Bornstein MM; Borradori L
    JAMA Dermatol; 2016 Dec; 152(12):1396-1398. PubMed ID: 27732708
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-laminin 332 mucous membrane pemphigoid with laryngeal involvement - adjuvant treatment with immunoadsorption and rituximab.
    Hügel R; Lang A; Lhotta K; Elsässer W; Gächter J; Messmer EM; Schmidt E
    J Dtsch Dermatol Ges; 2018 Jul; 16(7):897-900. PubMed ID: 29927519
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngeal mucous membrane pemphigoid: transnasal laryngoscopy to highlight a severe case.
    Watters CTM; Miller B; Karagama Y
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334770
    [No Abstract]   [Full Text] [Related]  

  • 17. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.
    Baniel A; Oestreicher-Kedem Y; Peled A; Bar-Ilan E; Geller S; Sprecher E; Baum S
    Clin Exp Dermatol; 2021 Jul; 46(5):915-919. PubMed ID: 33811681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mucous membrane pemphigoid with rituximab.
    Heelan K; Walsh S; Shear NH
    J Am Acad Dermatol; 2013 Aug; 69(2):310-1. PubMed ID: 23866864
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to "Treatment of mucous membrane pemphigoid with rituximab".
    Ahmed AR; Shetty S
    J Am Acad Dermatol; 2013 Aug; 69(2):311-2. PubMed ID: 23866865
    [No Abstract]   [Full Text] [Related]  

  • 20. IgM ocular cicatricial pemphigoid: a unique insight into the immune system.
    Tazudeen N; Au S; Pewitt J; Tu E; Aronson IK
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.